The U.S. Codex Office needs more funding – here’s why
On May 25, 2023, the Biotechnology Innovation Organization (BIO) and dozens of other …
IRA means 40% reduction in new drugs over 10 years, report finds
The drug price controls in the Inflation Reduction Act (IRA) will have a …
FDA approves Pfizer’s RSV vaccine for adults over age 60
Pfizer’s ABRYSVO vaccine for respiratory syncytial virus (RSV) received U.S. Food and Drug …
BIO-backed bills that would support startups passed by House
Two bills to create a healthy investment environment for biotech startups passed the …
Breaking down the EU Pharmaceutical Package: What U.S. companies should know
The EU Pharmaceutical Package is a series of legislative proposals that aims to, …
Ticking time bomb: reviving Lyme disease awareness
Along with climate change comes longer, warmer months, which means an extended tick …
EDITORS' CHOICE
IRA means 40% reduction in new drugs over 10 years, report finds
The drug price controls in the Inflation Reduction Act (IRA) will have a far more serious impact on new drug development than previously expected, says …
LATEST NEWS
The U.S. Codex Office needs more funding – here’s why
On May 25, 2023, the Biotechnology Innovation Organization (BIO) and dozens of other biotechnology organizations sent a letter to congressional leaders calling for more funding …
IRA means 40% reduction in new drugs over 10 years, report finds
The drug price controls in the Inflation Reduction Act (IRA) will have a far more serious impact on new drug development than previously expected, says …
FDA approves Pfizer’s RSV vaccine for adults over age 60
Pfizer’s ABRYSVO vaccine for respiratory syncytial virus (RSV) received U.S. Food and Drug Administration (FDA) approval for use in adults over age 60 on May …
BIO-backed bills that would support startups passed by House
Two bills to create a healthy investment environment for biotech startups passed the House late May 30 with overwhelming bipartisan support. The legislation was also …
Breaking down the EU Pharmaceutical Package: What U.S. companies should know
The EU Pharmaceutical Package is a series of legislative proposals that aims to, among other things, improve access, affordability, and availability of medicinal products across …
HEALTH
Ticking time bomb: reviving Lyme disease awareness
340B legislation advances in U.S. House
Texas mifepristone ruling undermines FDA, experts say
A Texas court’s attempt to hold on federal approval of mifepristone is an unprecedented attempt at undermining the Food and Drug Administration (FDA) approval process, says BIO.
AGRICULTURE
Climate Change
Ticking time bomb: reviving Lyme disease awareness
Along with climate change comes longer, warmer months, which means an extended tick season. With more time spent outdoors, there’s …
Federal Policy
340B legislation advances in U.S. House
State Policy
World Vaccine Congress addresses vaccine hesitancy, infrastructure, policy
The World Vaccine Congress 2023 convened in Washington, D.C., from April 3-6 to discuss a host of issues affecting vaccine uptake …
4 things for biotech to watch in the 2023 state legislatures
2022 midterms recap: what happened and what the results mean for biotech
How Dobbs v. Jackson is affecting vaccine innovation
Illinois announces $5 million grant-match program to boost innovation
International
Bio's View
The U.S. Codex Office needs more funding – here’s why
On May 25, 2023, the Biotechnology Innovation Organization (BIO) and dozens of other biotechnology organizations sent a letter to congressional …

